Welcome to medications.com

Lithobid Information

What's inside Lithobid

Lithobid Active Ingredients: lithium carbonate, details.
Lithobid Dosages & Strengths
Strength Format Route Strength Class
Lithobid 300 mg tablet, extended release oral 1.0 each OTC

Recent Lithobid Side Effects

Posted by princess2aa over 2 years ago
the shakes, stomache,a rash on my chest and on the back of my neck.

Posted by rocahotgirl over 5 years ago
dizzy

Posted by rivambm over 5 years ago
hand tremors, decreased balance, dry mouth and eyes, twitches


Lithobid in the News

Noven Appoints Michael D. Price Chief Financial Officer - Genetic Engineering News (press release)
Products currently marketed through the Noven/JDS sales infrastructure consist of Pexeva(R) (paroxetine mesylate) and Lithobid(R) (lithium carbonate). ...
Thu Nov 15 17:37:23 -0500 2007

Noven Announces Results of Phase 3 Clinical Study of Once-Daily ... - Business Wire (press release)
all 23 news articles
Mon Oct 08 05:06:52 -0400 2007

Noven Announces Share Repurchase Program - PharmaLive.com (press release)
Products currently marketed through the JDS psychiatry sales infrastructure include Pexeva(R) (paroxetine mesylate) and Lithobid(R) (lithium carbonate). ...
Wed Sep 05 05:54:13 -0400 2007


Lithobid Chemical Information

lithium carbonate - The carbonate salt of lithium, a monovalent cation with antimanic activity. Lithium carbonate interferes with transmembrane sodium exchange in nerve cells by affecting sodium, potassium-stimulated adenosine triphosphatase (Na+, K+-ATPase); altering the release of neurotransmitters; reducing cyclic adenosine monophosphate (cAMP) concentrations and modulating cAMP second-messenger processes; and suppressing signal transduction pathways through the depletion of intracellular inositol and inhibition of the enzyme, glycogen synthase-kinase-3 (GSK-3). The exact mechanism through which lithium carbonate exerts its mood-stabilizing effect is not fully known.



Related Drugs
Related drugs contain similar ingredients


ADVERTISEMENT
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com